Concord Medical Services Holdings Limited

DB:C2C Stock Report

Market Cap: €30.8m

Concord Medical Services Holdings Past Earnings Performance

Past criteria checks 0/6

Concord Medical Services Holdings has been growing earnings at an average annual rate of 5.1%, while the Healthcare industry saw earnings growing at 5.8% annually. Revenues have been growing at an average rate of 23.5% per year.

Key information

5.1%

Earnings growth rate

5.2%

EPS growth rate

Healthcare Industry Growth15.7%
Revenue growth rate23.5%
Return on equity-33.8%
Net Margin-80.3%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Concord Medical Services Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

DB:C2C Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 24472-3793660
31 Mar 24505-3383760
31 Dec 23537-2983860
30 Sep 23575-3823890
30 Jun 23612-4663920
31 Mar 23542-4783820
31 Dec 22472-4903730
30 Sep 22455-6673720
30 Jun 22437-8453720
31 Mar 22461-8333870
31 Dec 21486-8214010
30 Sep 21409-7263760
30 Jun 21333-6313500
31 Mar 21278-6513350
31 Dec 20223-6703210
30 Sep 20202-6063360
30 Jun 20182-5413520
31 Mar 20190-5473480
31 Dec 19198-5533450
30 Sep 19192-4623420
30 Jun 19185-3713390
31 Mar 19188-3653260
31 Dec 18191-3593140
30 Sep 18210-3352870
30 Jun 18230-3112600
31 Mar 18280-2972710
31 Dec 17331-2842810
30 Sep 17369-2992930
30 Jun 17407-3133050
31 Mar 17433-2812890
31 Dec 16455-2622760
30 Sep 16492-3222730
30 Jun 16546-1942560
31 Mar 16591-1392590
31 Dec 15616-782460
30 Sep 15405961980
30 Jun 155041041680
31 Mar 156151021540
31 Dec 14607991490
30 Sep 14552911690
30 Jun 141,061992080
31 Mar 14502811900
31 Dec 13563751890

Quality Earnings: C2C is currently unprofitable.

Growing Profit Margin: C2C is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: C2C is unprofitable, but has reduced losses over the past 5 years at a rate of 5.1% per year.

Accelerating Growth: Unable to compare C2C's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: C2C is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (30.9%).

Return on Equity

High ROE: C2C has a negative Return on Equity (-33.81%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/10/26 18:05
End of Day Share Price 2024/07/29 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Concord Medical Services Holdings Limited is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ye YinBrean Capital
Jessica LiChina International Capital Corporation Limited
Michael WuJMP Securities